Modern Solution for Modern Cataract Surgery

Post author: Dr Endl

OMIDRIA is making waves in refractive cataract surgery, and Dr. Michael Endl, a Buffalo, New York ophthalmologist and keen OMIDRIA user, joined us to chat about it. In this video, Dr. Endl talks about the impact of Rayner’s OMIDRIA on his practice and drop burden, the surgical experience for doctors, and what it all means for patient and clinic. Patients expect modern refractive cataract surgeries to be fast and seamless, and Dr. Endl explains how OMIDRIA can play a role in reaching that goal.

INDICATIONS AND USAGE

OMIDRIA® is added to ophthalmic irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.

IMPORTANT SAFETY INFORMATION

OMIDRIA must be added to irrigating solution prior to intraocular use.

OMIDRIA is contraindicated in patients with a known hypersensitivity to any of its ingredients.

Systemic exposure to phenylephrine may cause elevations in blood pressure.

Use OMIDRIA with caution in individuals who have previously exhibited sensitivities to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory drugs (NSAIDs), or have a past medical history of asthma.

The most commonly reported adverse reactions at ≥ 2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.

Please see the Full Prescribing Information for OMIDRIA.

You are encouraged to report Suspected Adverse Reactions to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.